BRCA2 and prostate cancer: Although the contribution of the homologous recombination mediators BRCA1 and BRCA2 to prostate cancer has been previously investigated, this is the first study to address the importance of RAD51 genetics in the occurrence of sporadic prostate cancer [26, 29].